Lensar (LNSR) Interest Coverage Ratio Growth (3y) (2022 - 2026)
Lensar (LNSR) Interest Coverage Ratio Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | -2.41% |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 9.28% |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 100.22% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -35.05% |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn | 46.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.86% |
| Dec 31, 2025 | 52.54% |
| Sep 30, 2025 | 4.08% |
| Jun 30, 2025 | 34.87% |
| Mar 31, 2025 | 38.68% |
| Dec 31, 2024 | 70.72% |
| Sep 30, 2024 | 18.20% |
| Jun 30, 2024 | -75.83% |
| Mar 31, 2024 | 12.48% |
| Dec 31, 2023 | -41.54% |
| Sep 30, 2023 | 55.19% |
| Jun 30, 2023 | 25.59% |
| Mar 31, 2023 | 45.25% |
| Dec 31, 2022 | -55.96% |
| Sep 30, 2022 | 60.61% |